×
Nihon Kohden Goodwill and Intangible Assets 2015-2024 | NHNKY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Nihon Kohden goodwill and intangible assets from 2015 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
View More
Nihon Kohden Goodwill and Intangible Assets 2015-2024 | NHNKY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Nihon Kohden goodwill and intangible assets from 2015 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$233.2B
Intuitive Surgical (ISRG)
$171.7B
Alcon (ALC)
$47.9B
IQVIA Holdings (IQV)
$43.7B
IDEXX Laboratories (IDXX)
$42.2B
Edwards Lifesciences (EW)
$40.5B
DexCom (DXCM)
$27.6B
STERIS (STE)
$23.8B
SONOVA HOLDING (SONVY)
$21.2B
Waters (WAT)
$19.5B
Hologic (HOLX)
$19B
Sysmex ADR (SSMXY)
$12.6B
Fresenius Medical Care AG KGaA (FMS)
$12.3B
Teleflex (TFX)
$11.4B
Globus Medical (GMED)
$9.4B
Penumbra (PEN)
$7.3B
Glaukos (GKOS)
$6.7B
Masimo (MASI)
$6.1B
TransMedics (TMDX)
$5.2B
Integer Holdings (ITGR)
$4.2B
PROCEPT BioRobotics (PRCT)
$4.1B
Tandem Diabetes Care (TNDM)
$2.8B
LivaNova (LIVN)
$2.8B
Veracyte (VCYT)
$2.6B
Inari Medical (NARI)
$2.6B
Elekta AB (EKTAY)
$2.5B
RxSight (RXST)
$2.1B
Integra LifeSciences Holdings (IART)
$1.3B
Pulse Biosciences (PLSE)
$1.2B
OPKO Health (OPK)
$1.2B